BodMed
- Biotech or pharma, therapeutic R&D
BodMed is a clinical-stage biotech dedicated to the development of non-viral, non-LNP-based Inhaled and Oral "Mucosal RNA Medicines" (mRNA and siRNA), targeting mucosa-related diseases (e.g., Lung Cancer, Cystic Fibrosis, GI tract tumors, IBD, etc.).
Address
SuzhouJiangsu
China
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}